Evidence map›Paper›PMID 33038341›Full record

ArticleThe Annals of thoracic surgery2021

Maintaining Surgical Treatment of Non-Small Cell Lung Cancer During the COVID-19 Pandemic in Paris.

Jean-Baptiste Leclère, Ludovic Fournel, Harry Etienne, Charbel Al Zreibi, Ilaria Onorati, Arnaud Roussel, Yves Castier, Emmanuel Martinod, Françoise Le Pimpec-Barthes, Marco Alifano and 3 more

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Annals of thoracic surgery, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 1 country.

Jean-Baptiste LeclèreDepartment of Vascular Surgery, Thoracic Surgery, and Lung Transplantation, Hôpital Bichat, Université de Paris, Paris, France.
Ludovic FournelDepartment of Thoracic Surgery, Hôpital Cochin, Université de Paris, Paris, France.
Harry EtienneDepartment of Thoracic and Vascular Surgery, Hôpital Tenon, Sorbonne Université, Paris, France.
Charbel Al ZreibiDepartment of General Thoracic Surgery, Oncology, and Lung Transplantation, Hôpital Européen Georges-Pompidou, Université de Paris, Paris, France.
Ilaria OnoratiDepartment of Thoracic and Vascular Surgery, Hôpital Avicenne, Université Sorbonne Paris Nord, Paris, France.
Arnaud RousselDepartment of Vascular Surgery, Thoracic Surgery, and Lung Transplantation, Hôpital Bichat, Université de Paris, Paris, France.
Yves CastierDepartment of Vascular Surgery, Thoracic Surgery, and Lung Transplantation, Hôpital Bichat, Université de Paris, Paris, France.
Emmanuel MartinodDepartment of Thoracic and Vascular Surgery, Hôpital Avicenne, Université Sorbonne Paris Nord, Paris, France.
Françoise Le Pimpec-BarthesDepartment of General Thoracic Surgery, Oncology, and Lung Transplantation, Hôpital Européen Georges-Pompidou, Université de Paris, Paris, France.
Marco AlifanoDepartment of Thoracic Surgery, Hôpital Cochin, Université de Paris, Paris, France.
Jalal AssouadDepartment of Thoracic and Vascular Surgery, Hôpital Tenon, Sorbonne Université, Paris, France.
Pierre MordantDepartment of Vascular Surgery, Thoracic Surgery, and Lung Transplantation, Hôpital Bichat, Université de Paris, Paris, France. Electronic address: pierre.mordant@aphp.Fr.
Thoracic Surgery Units of Paris Public Hospitals
Université Paris Cité · FRHôpital Bichat-Claude-Bernard · FRSorbonne Université · FRHôpital Avicenne · FRHôpital Cochin · FRHôpital Européen Georges-Pompidou · FRHôpital Tenon · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe coronavirus disease 2019 (COVID-19) outbreak was officially declared in France on March 14, 2020. The objective of this study is to report the incidence and outcome of COVID-19 after surgical resection of non-small cell lung cancer in Paris Public Hospitals during the pandemic.

methodsWe retrospective analyzed a prospective database including all patients who underwent non-small cell lung cancer resection between March 14, 2020, and May 11, 2020, in the 5 thoracic surgery units of Paris Public Hospitals. The primary endpoint was the occurrence of SARS-CoV-2 infection during the first 30 days after surgery.

resultsStudy group included 115 patients (male 57%, age 64.6 ± 10.7 years, adenocarcinoma 66%, cT1 62%, cN0 82%). During the first month after surgery, 6 patients (5%) were diagnosed with COVID-19. As compared with COVID-negative patients, COVID-positive patients were more likely to be operated on during the first month of the pandemic (100% vs 54%, P = .03) and to be on corticosteroids preoperatively (33% vs 4%, P = .03). Postoperative COVID-19 was associated with an increased rate of readmission (50% vs 5%, P = .004), but no difference in 30-day morbidity (for the study group: grade 2, 24%; grade 3, 7%; grade 4, 1%) or mortality (n = 1 COVID-negative patient, 0.9%). Immediate oncologic outcomes did not differ significantly between groups (R0 resection 99%, nodal upstaging 14%, adjuvant chemotherapy 29%).

conclusionsDuring the COVID-19 pandemic, surgical treatment of non-small cell lung cancer was associated with a rate of postoperative COVID-19 of 5% with a significant impact on readmissions but not on other outcomes studied.

Indexed as

PandemicsAgedCarcinoma, Non-Small-Cell LungCOVID-19FemaleFranceHumansIncidenceLung NeoplasmsMaleMiddle AgedPatient ReadmissionPneumonectomyRetrospective StudiesSARS-CoV-2

Identifiers

PMID33038341
PMCPMC7543779
OpenAlexW3092401882

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.